Is telehealth allowed to prescribe Ozempic?

In the rapidly evolving landscape of weight management, GLP-1 medications like Wegovy, Ozempic, and Mounjaro have become game-changers for many struggling with obesity. But a common question remains: Can you legally get these medications through telehealth services without an in-person visit? The answer is generally yes—with some important state-specific nuances to understand.

The Federal Telehealth Landscape for GLP-1 Medications

First, let’s clear up a common misconception: GLP-1 weight loss medications are NOT controlled substances under federal law. This means they don’t fall under the Ryan Haight Act’s in-person examination requirements that apply to medications like Adderall or certain pain medications.

From a federal perspective, there are no restrictions preventing licensed healthcare providers from prescribing GLP-1 medications via telehealth after a proper virtual consultation. During the COVID-19 pandemic, telehealth regulations were broadly relaxed, and while some of those flexibilities have special status (particularly for controlled substances), the ability to prescribe non-controlled medications like Wegovy via telehealth remains firmly established.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Regulations for Weight Loss Medications

While federal law permits telehealth prescribing of GLP-1s, state laws can impose additional requirements. Here’s what you need to know about key states:

States with No In-Person Requirements

These states allow fully virtual care for GLP-1 weight loss medications:

• California: Embraces telehealth fully; no in-person exam required
• Connecticut: Virtual consultations sufficient; requires behavioral counseling alongside medication
• Florida: No in-person mandate, but requires follow-up visits at least every 3 months
• Illinois: Completely virtual care permitted with no special restrictions
• New York: Fully supportive of telehealth for weight management
• Pennsylvania: No in-person requirements for GLP-1 prescriptions
• Washington: Pioneer in telehealth access; no special restrictions

States Requiring an Initial In-Person Visit

These states require an in-person examination before or shortly after starting GLP-1 medications:

• Arkansas: First examination must be conducted in-person
• Delaware: Initial physical examination required in-person
• Georgia: In-person examination required prior to telehealth prescribing
• Mississippi: Must see patient in-person at least once
• New Jersey: Comprehensive in-person exam plus lab work required initially
• North Dakota: Initial hands-on evaluation expected for weight loss treatment
• South Carolina: Must examine patient in-person first
• Texas: Initial in-person exam generally expected
• Utah: Initial in-person examination encouraged
• Virginia: Physical exam and lab work required initially

What to Expect from a Legitimate Telehealth Weight Loss Consultation

When seeking GLP-1 medications through telehealth, a reputable provider like Klarity Health will:

1. Conduct a comprehensive medical evaluation (via video consultation in states where permitted)
2. Verify your BMI and weight-related health concerns
3. Review your medical history and current medications
4. Discuss potential risks and benefits of GLP-1 therapy
5. Create a treatment plan that includes lifestyle modifications
6. Schedule regular follow-ups to monitor progress and manage side effects

Most states require patients to have a BMI ≥30, or ≥27 with weight-related complications like high blood pressure or diabetes, to qualify for these medications. Klarity Health providers adhere to these clinical guidelines while making the process as convenient as possible.

Provider Qualifications Matter

Who can prescribe GLP-1 medications varies by state:

• Physicians (MDs/DOs) can prescribe in all states via telehealth (if licensed in your state)
• Nurse Practitioners (NPs) have full independent prescribing authority in about half of states (including CA, NY, WA)
• Physician Assistants (PAs) typically can prescribe with varying levels of physician supervision

At Klarity Health, we ensure all our providers are appropriately licensed and follow state-specific rules, giving patients confidence in their care.

Red Flags to Watch For

Not all telehealth services are created equal. Be cautious of any platform that:

• Guarantees a prescription without a thorough evaluation
• Sells ‘compounded’ versions of semaglutide (FDA banned most compounding in 2025)
• Doesn’t schedule follow-ups or monitor your progress
• Lacks transparency about provider credentials

Insurance Coverage and Accessibility

While telehealth has made GLP-1 medications more accessible, insurance coverage remains variable. Klarity Health works with many insurance plans and offers transparent pricing for those paying out-of-pocket, helping patients navigate the often-complex coverage landscape for weight management medications.

The Future of Telehealth for Weight Management

The regulatory landscape continues to evolve, but the trend is toward greater telehealth access with appropriate safeguards. Telehealth has proven particularly valuable for weight management, as it removes barriers to care while maintaining clinical standards.

For those concerned about state-specific requirements, Klarity Health stays current with changing regulations to ensure compliant care. Our providers are licensed in multiple states and understand the nuances of each state’s laws regarding GLP-1 prescriptions.

Conclusion

In most states, you can legally receive GLP-1 weight loss medications through telehealth services, though requirements vary. The key is working with a reputable telehealth provider that follows state-specific regulations and maintains high clinical standards.

If you’re considering GLP-1 medications for weight management, Klarity Health offers convenient telehealth consultations with licensed providers who understand both the clinical aspects of weight management and the regulatory landscape. Our transparent approach ensures you receive appropriate care that complies with all applicable laws while prioritizing your health outcomes.

Ready to explore whether GLP-1 medications might be right for you? Schedule a consultation with Klarity Health today to discuss your options with a licensed healthcare provider.

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025 (www.axios.com) (www.dea.gov). Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)
Sources newer than 2024: 15 of 18 sources (most sources are 2024–2025; older sources used only for baseline context)

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid